| Keywords: |
immunohistochemistry; adult; cancer chemotherapy; protein expression; treatment response; cancer surgery; young adult; clinical trial; neutropenia; cisplatin; drug dose reduction; antineoplastic agents; pyridines; cancer radiotherapy; letter; protein blood level; multiple cycle treatment; vomiting; tumor marker; disease progression; teratoma; neoplasms, germ cell and embryonal; headache; piperazines; neoplasms, second primary; cyclin-dependent kinases; 6 acetyl 8 cyclopentyl 5 methyl 2 [5 (1 piperazinyl) 2 pyridinylamino] 8h pyrido[2,3 d]pyrimidin 7 one; retinoblastoma protein; embryonal carcinoma; non seminomatous germinoma; cyclin dependent kinase 4; alpha fetoprotein; chorionic gonadotropin; cyclin dependent kinase 6; gonadotropin blood level; growing teratoma syndrome
|
